Company Website: http://www.owcpharma.com/
Company Website: http://www.owcpharma.com/
Recent Articles
- Revolutionizing In-Car Audio: Audiokinetic's Role in NEVO E07
- FibroBiologics Q3 2024 Results: Advancements in Cell Therapy
- American Healthcare REIT Boosts 2024 Guidance Amid New Acquisitions
- Upcoming TEN, Ltd. Conference Call for Q3 Earnings and Webcast
- Tempest Therapeutics Unveils Progress and Financial Insights
- Sempra Earns Spot as a Top Global Company for 2024 Recognition
- CarGurus Embraces Opportunity at RBC Capital Markets Conference
- UTI-Canton Recognized as a Veteran-Friendly Educational Hub
- Willow Lane Acquisition Corp. Successfully Completes IPO
- Thunder Bridge Capital Partners IV Moves Forward with Coincheck Merger
- ONEOK's Upcoming Participation in Global Energy Conference
- Nature's Miracle Holding Inc. Completes $3 Million Offering
- Kentucky First Federal Bancorp's Latest Earnings Analysis
- Matson's Upcoming Presentation at Investment Conference
- LGI Homes Launches $400 Million Senior Notes Offering
- SurgePays' Q3 2024 Results Reveal Strategic Growth Path
- Hyperfine, Inc. Sees Significant Growth in Third Quarter
- Topgolf Callaway Brands Exceeds Q3 2024 Expectations
- ReShape Lifesciences' Q3 Financial Announcements and Updates
- FibroGen Shows Promising Growth with Latest Financial Report
- CNB Financial Corporation Declares Significant Quarterly Dividend
- Select Water Solutions Engages in Fireside Chat Series
- Locafy Limited: Highlights from Fiscal Year 2024 Performance
- PubMatic Reports Impressive Growth in Q3 Financial Results
- Psychemedics Corporation Reports Q3 Insights and Future Outlook
- Runway Growth Finance Corp. Exhibits Strong Q3 Results
- Lifecore Biomedical Set to Showcase at Investment Conference
- Fractyl Health's Q3 2024 Financial Insights and Operational Updates
- Perspective Therapeutics: Significant Developments and Fiscal Updates
- Urgently's Q3 2024 Performance Highlights and Future Outlook
- Codexis Welcomes Dr. Raymond De Vré to Its Board of Directors
- GEN Restaurant Group Reports Strong Q3 Performance in 2024
- W. P. Carey Inc. Successfully Prices €600 Million Senior Notes
- Crinetics Pharmaceuticals Unveils Neuroendocrine Tumor Advances
- Rocket Companies Reports Strong Q3 Performance and Growth
- SI-BONE Achieves Impressive Growth in Recent Financial Report
- Integral Ad Science Shows Robust Performance in Q3 2024
- Safe Harbor Financial Shows Growth in Recent Financial Results
- Genpact Welcomes Jinsook Han as Chief Strategy Officer
- Alpine Income Property Trust Boosts Investment Strategy in 2024
- Etsy to Engage Investors at Key Conferences Soon
- Pure Storage Prepares for Q3 2025 Financial Conference Call
- Dave Inc. Reports Record Growth in Financial Results
- Radiant Logistics Sees Growth Amid Economic Challenges
- Orchestra BioMed Achieves Key Financial and Operational Progress
- ICU Medical and Otsuka Forge Alliance for Advanced IV Solutions
- Viking Therapeutics Excited to Share VK2809 Phase 2b Findings
- Theravance Biopharma's Q3 2024 Results & Future Vision
- Biohaven's Strategic Advances and Financial Insights for Q4 2024
- AllianceBernstein Reports Decrease in AUM for October 2024